C0681814||Studying
C0286651||Atorvastatin
C1328819||small molecule
C1254351||drug
C0860803||high glucose
C0235032||neurotoxicity
C0085262||PC12 cells
C0068355||NADPH oxidase
C0162772||reactive oxygen species
C0162772||reactive oxygen species
C0068355||NADPH oxidase
C0068355||NADPH oxidase
C0014429||activation
C0020456||hyperglycemia
C0040300||tissues
C0681814||study
C0068355||NOXs
C0860803||high glucose
C0860803||high glucose
C0600688||toxic effect
C0027757||neural tissues
C0030664||pathologies
C0068355||NOX enzymes
C1328819||small molecules
C0360714||Statins
C0242606||oxidative stress
C0068355||NADPH oxidase
C1524081||inhibition
C0040300||tissues
C0027757||neural
C0068355||NOXs
C0860803||high glucose
C0286651||Atorvastatin
C1328819||small molecule
C0443264||modulate
C1151146||NOXs activity
C0027882||neural cells
C0085262||PC12 cells
C0332293||treated with
C0860803||high glucose
C0150312||presence
C0286651||Atorvastatin
C0007620||cell viability
C2986858||MTT assay
C3463810||protein expressions profile
C0068355||NADPH oxidase
C0599161||RT-PCR
C0005863||western blotting
C0162772||reactive oxygen species
C0024643||malondialdehyde
C0024643||malondialdehyde
C0017262||Gene
C1171362||protein expression
C0068355||NADPH oxidase
C0162772||reactive oxygen species
C0024643||malondialdehyde
C0860803||high glucose
C0085262||PC12 cells
C0286651||Atorvastatin
C0860803||high glucose
C0068355||NOXs
C0162772||reactive oxygen species
C0024643||malondialdehyde
C0702240||elevation
C0184511||improve
C0007620||cell viability
C0860803||high glucose
C1151146||NOXs activity
C0162772||reactive oxygen species
C0024643||malondialdehyde
C0027757||neural tissues
C0286651||Atorvastatin
C1328819||small molecule
C1254351||NOX inhibitor drug
C0342257||diabetic complications
C0442874||neuropathy